"human-papilloma-virus"

The vaccine, developed by Pune-based Serum Institute of India (SII), is 97% effective in preventing cervical cancer

Being indigenously made, the Cervavac vaccine is expected to cost Rs 200-400 as against the imported ones available for Rs 2,800 to Rs 3,300 per dose.